Neuropsychiatric Disorders
Clinical research includes therapies for generalized anxiety disorder, with studies examining treatment options for patients who have had an inadequate response to existing care. The portfolio also covers both standalone and adjunctive approaches for anxiety symptoms.
- Generalized Anxiety Disorder
- Adjunctive therapy
- Anxiety symptom management
Work in this area reflects a focus on psychiatric treatment for persistent anxiety symptoms and response-limited patient populations.
Mood Disorders
The sponsor funds research in major depressive disorder and bipolar I disorder, including treatment of manic episodes and mixed features. These studies address acute mood instability and depressive symptoms in adults needing additional therapeutic options.
- Major Depressive Disorder
- Bipolar I Disorder
- Mania
Its clinical activity in this domain spans both depressive and manic presentations within mood disorder care.
Alzheimer’s Disease-Related Behavioral Symptoms
Research also targets behavioral and psychiatric complications of Alzheimer’s disease, including agitation and psychosis associated with dementia. These trials focus on symptom control in patients with neurodegenerative disease.
- Agitation Associated with Alzheimer’s Dementia
- Psychosis associated with Alzheimer’s disease
- Dementia-related behavioral symptoms
This area reflects an emphasis on behavioral pathology in older adults living with cognitive decline.
Psychiatric Pharmacotherapy
The sponsor’s trial portfolio is centered on pharmacologic treatment across several psychiatric and neurobehavioral conditions, with studies evaluating agents used in both monotherapy and adjunctive treatment settings. The research spans anxiety, depression, bipolar illness, and dementia-related neuropsychiatric symptoms.
- Monotherapy treatment
- Adjunctive treatment
- Psychiatric symptom control
Clinical activity is concentrated in disorders where central nervous system therapeutics are used to address complex symptom profiles.
